Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept
Clinical trial NCT04947137 · COMPLETED
Trial details
- NCT number
- NCT04947137
- Sponsor
- Navidea Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2022-01-21
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.